20182019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Anna Maria Mileo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells

Matteoni, S., Abbruzzese, C., Matarrese, P., De Luca, G., Mileo, A. M., Miccadei, S., Schenone, S., Musumeci, F., Haas, T. L., Sette, G., Carapella, C. M., Amato, R., Perrotti, N., Signore, M. & Paggi, M. G., May 17 2019, In : Journal of Experimental and Clinical Cancer Research. 38, 1, p. 202

Research output: Contribution to journalArticle

  • Lenvatinib for the treatment of renal cell carcinoma

    Roviello, G., Corona, S. P., Bozza, G., Aieta, M., Generali, D., Rodriquenz, M. G., Mileo, A. M., Imperatori, M., Ianza, A., Conca, R. & Sobhani, N., May 2018, In : Expert Opinion on Investigational Drugs. 27, 5, p. 507-512 6 p.

    Research output: Contribution to journalReview article